Indo US Bio-Tech Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 33.50 | 23.58 | 22.19 |
| Operating Expense | 28.80 | 18.02 | 17.05 |
| Net Profit | 3.68 | 5.05 | 4.36 |
| Net Profit Margin | 10.99 | 21.42 | 19.65 |
| Earning Per Share | 1.86 | 2.52 | 2.16 |
| EBIDTA | 4.80 | 5.59 | 5.05 |
| Effective Tax Rate | 6.38 | TBA | -0.19 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 33.50 |
| Operating Expense | 28.80 |
| Net Profit | 3.68 |
| Net Profit Margin | 10.99 |
| Earning Per Share | 1.86 |
| EBIDTA | 4.80 |
| Effective Tax Rate | 6.38 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 72.84 | 61.74 | 50.05 |
| Operating Expenses Annual | 62.04 | 52.37 | 43.13 |
| Operating Profit Annual | 11.11 | 9.40 | 7.10 |
| Interest Annual | 1.51 | 1.18 | 1.18 |
| Depreciation | 0.80 | 0.83 | 0.44 |
| Net Profit Annual | 8.25 | 7.24 | 5.24 |
| Tax Annual | 0.55 | 0.15 | 0.25 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 72.84 |
| Operating Expenses Annual | 62.04 |
| Operating Profit Annual | 11.11 |
| Interest Annual | 1.51 |
| Depreciation | 0.80 |
| Net Profit Annual | 8.25 |
| Tax Annual | 0.55 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.19 | 0.05 | 0.13 |
| Cash Flow from Operations | -4.58 | 0.53 | 2.91 |
| Cash Flow from Investing | 4.28 | -6.67 | -5.40 |
| Cash Flow from Financing | 1.22 | 6.29 | 2.41 |
| Cash Flow at the End | 1.10 | 0.19 | 0.05 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.19 |
| Cash Flow from Operations | -4.58 |
| Cash Flow from Investing | 4.28 |
| Cash Flow from Financing | 1.22 |
| Cash Flow at the End | 1.10 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 15.27 | 15.24 | 14.25 |
| PBIT Margin (%) | 14.17 | 13.90 | 13.37 |
| PBT Margin (%) | 4.85 | 2.30 | 2.22 |
| Net PROFIT Margin (%) | 11.33 | 11.73 | 10.47 |
| Return On Networth / Equity (%) | 14.07 | 15.51 | 17.35 |
| Return On Networth /Employed (%) | 14.18 | 14.37 | 15.50 |
| Return On Assets (%) | 11.33 | 12.08 | 12.14 |
| Total Debt / Equity (X) | 0.22 | 0.26 | 0.40 |
| Asset Turnover Ratio (%) | 1 | 1.03 | 1.16 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 15.27 |
| PBIT Margin (%) | 14.17 |
| PBT Margin (%) | 4.85 |
| Net PROFIT Margin (%) | 11.33 |
| Return On Networth / Equity (%) | 14.07 |
| Return On Networth /Employed (%) | 14.18 |
| Return On Assets (%) | 11.33 |
| Total Debt / Equity (X) | 0.22 |
| Asset Turnover Ratio (%) | 1 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 6.69 | 7.37 | 5.54 |
| Total Current Assets Annual | 73.09 | 59.91 | 47.06 |
| Non Current Assets Annual | 11.36 | 9.56 | 8.52 |
| Total Shareholders Funds Annual | 62.75 | 54.50 | 38.88 |
| Total Assets Annual | 84.46 | 69.47 | 55.57 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 6.69 |
| Total Current Assets Annual | 73.09 |
| Non Current Assets Annual | 11.36 |
| Total Shareholders Funds Annual | 62.75 |
| Total Assets Annual | 84.46 |
No Data Availabe
